Blog

A High-Level Hearing on the Future of the EU’s Pharmaceutical Legislation – European Cancer Organisation

ECO/LinkedIn

Jul 12, 2025, 15:15

A High-Level Hearing on the Future of the EU’s Pharmaceutical Legislation – European Cancer Organisation

European Cancer Organisation shared on LinkedIn:

“This week in Strasbourg

The European Parliament’s Intergroup on Cancer and Rare Diseases held a high-level hearing on the future of the EU’s pharmaceutical legislation.

The session was co-chaired MEPs Stine Bosse, Tilly Metz, Alessandra Moretti, Tomislav Sokol, and Vlad Voiculescu.

Policymakers, medical professionals and patient advocates came together to discuss the legislation, including presentations from representatives of the ECO community:

Denis Lacombe, CEO of the European Organisation for Research and Treatment of Cancer, on the topic of treatment optimisation, and
Lydie Meheus from the Anticancer Fund on the topic of drug repurposing.

Next step The EU Parliament, Council, and Commission will negotiate the final text.

Read more about the hearing in the official press release.”

More posts featuring ECO.

Alessandra Moretti cancer Denis Lacombe ECO European Parliament’s Intergroup Lydie Meheus OncoDaily Oncology rare diseases Stine Bosse Tilly Metz Tomislav Sokol Vlad Voiculescu

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers